betamethasone (Q416132)

betamethasone (English)

17 November 2016

1 reference

C₂₂H₂₉FO₅

1 reference

betamethasone (English)

17 November 2016

canonical SMILES

CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C

1 reference

betamethasone (English)

17 November 2016

isomeric SMILES

C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C

1 reference

betamethasone (English)

17 November 2016

defined daily dose

0.4 milligram

route of administration

nasal administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=R01AD06

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

betamethasone (English)

1 reference

betamethasone (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

13 December 2016

seborrhoeic dermatitis

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

17 April 1961

1 reference

2 November 2018

https://drugs.ncats.io/drug/9842X06Q6M

http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/014602s059lbl.pdf

allergic rhinitis

start time

17 April 1961

approved by

1 reference

2 November 2018

https://drugs.ncats.io/drug/9842X06Q6M

http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/014602s059lbl.pdf

ulcerative colitis

start time

17 April 1961

approved by

1 reference

2 November 2018

https://drugs.ncats.io/drug/9842X06Q6M

http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/014602s059lbl.pdf

multiple sclerosis

start time

17 April 1961

approved by

1 reference

2 November 2018

https://drugs.ncats.io/drug/9842X06Q6M

http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/014602s059lbl.pdf

significant drug interaction

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

Achor-Smith syndrom

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

tendon rupture

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Nuclear receptor subfamily 3 group C member 1

subject has role

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7061

imported from Wikimedia project

17 August 2016

pregnancy category

US pregnancy category C

1 reference

English Wikipedia

subject has role

5-lipoxygenase inhibitor

1 reference

5 March 2018

selective glucocorticoid receptor agonist

1 reference

5 March 2018

anti-inflammatory agent

1 reference

InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

0 references

0 references

Betamethasone

0 references

Identifiers

InChI

1 reference

betamethasone (English)

17 November 2016

2 references

betamethasone (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

378-44-9

2 references

betamethasone (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=378-44-9

9 April 2021

1 reference

Betamethasone (English)

17 November 2016

2 references

betamethasone (English)

17 November 2016

Reaxys registry number

3176546

1 reference

betamethasone (English)

3 October 2016

ChEBI ID

3077

mapping relation type

2 references

BETAMETHASONE (English)

17 November 2016

International Chemical Identifier

InChI

InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1

1 reference

BETAMETHASONE (English)

17 November 2016

2 references

inferred from InChIKey

splash10-05i4-2930000000-bc11f96b96bcca3051a8

1 reference

MassBank accession ID

MSBNK-Eawag-EQ324201

0 references

MSBNK-Eawag-EQ324205

0 references

MSBNK-Waters-WA001161

0 references

MSBNK-Waters-WA001162

0 references

MSBNK-Waters-WA001163

0 references

MSBNK-Waters-WA001164

0 references

MSBNK-Waters-WA001165

0 references

MSBNK-Waters-WA001166

0 references

MSBNK-Waters-WA001167

0 references

SPLASH

0 references

splash10-00dj-3960000000-a7dc9d06200fd3114dc2

0 references

HSDB ID

3015

1 reference

Hazardous Substances Data Bank

28 October 2019

BETAMETHASONE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

betamethasone (English)

ECHA Substance Infocard ID

17 November 2016

100.006.206

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.006.206

27 December 2018

Betamethasone (English)

quotation

CAS no.: 378-44-9 (English)

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Betamethasone (English)

17 November 2015

1 reference

Guide to Pharmacology Ligand ID

Betamethasone (English)

publication date

17 November 2015

7061

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7061

D04.210.500.745.432.769.199

betamethasone (English)

17 November 2016

Betamethasone

0 references

MeSH concept ID

M0002437

0 references

MeSH tree code

0 references

0 references

1 reference

betamethasone (English)

17 November 2016

DrugBank ID

DB00443

1 reference

Human Metabolome Database ID

HMDB0014586

2 references

based on heuristic

inferred from InChIKey

2 references

betamethasone (English)

17 November 2016

MedlinePlus drug identifier

a682799

0 references

PatientsLikeMe treatment ID

0 references

1 reference

betamethasone (English)

17 November 2016

0 references

1 reference

1 reference

betamethasone (English)

electronic Essential Medicines List medicine ID

3 October 2016

0 references

1 reference

28 October 2013

Gran Enciclopèdia Catalana ID

betametasona

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0084211

0 references

KBpedia ID

BetamethasoneValerate

1 reference

KBpedia

https://docs.openalex.org/download-snapshot/snapshot-data-format

9 July 2020

Microsoft Academic ID

0 references

0 references

0 references

1 reference

26 January 2022

Quora topic ID

Betamethasone

0 references

Store medisinske leksikon ID

betametason

mapping relation type

0 references

1 reference